Business
MMJ PhytoTech Ltd (MMJJF) MediPharm Labs receives sales licence
Perth, Australia (ABN Newswire) - MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJ...
About this update from Medipharm Labs Corp.
[{"type":"text","content":"MMJ PhytoTech Ltd (MMJJF) MediPharm Labs receives sales licence\nPerth, Australia (ABN Newswire) - MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) (\"MMJ\") is pleased to attach a copy of a news release by MediPharm Labs Inc (\"MediPharm Labs\") (CVE:LABS) confirming that it has been issued a sales licence by Health Canada. MMJ owns 5.2 million shares and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs. To view the MediPharm Release, please visit:http://abnnewswire.net/lnk/600M1PPM \nAbout MMJ PhytoTech Ltd:MMJ PhytoTech Limited (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/ \nSource:MMJ PhytoTech Ltd\nContact:Investor and Media Enquiries:\nJason Conroy\nChief Executive Officer\nT: +61-2-8098-0819\nE: [email protected]\n \n ","length":1376,"tagName":"div"}]